These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 8182273)

  • 1. Anatomy of a trial: a historical view of the Monroe inactivated hepatitis A protective efficacy trial.
    Werzberger A; Kuter B; Shouval D; Mensch B; Brown L; Wiens B; Lewis J; Miller W; Sitrin R; Provost P
    J Hepatol; 1993; 18 Suppl 2():S46-50. PubMed ID: 8182273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness of hepatitis A vaccine in a former frequently affected community: 9 years' followup after the Monroe field trial of VAQTA.
    Werzberger A; Mensch B; Nalin DR; Kuter BJ
    Vaccine; 2002 Mar; 20(13-14):1699-701. PubMed ID: 11906754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis A vaccine.
    Nalin DR
    J Occup Environ Med; 1996 Dec; 38(12):1200-1. PubMed ID: 8978510
    [No Abstract]   [Full Text] [Related]  

  • 4. A controlled trial of a formalin-inactivated hepatitis A vaccine in healthy children.
    Werzberger A; Mensch B; Kuter B; Brown L; Lewis J; Sitrin R; Miller W; Shouval D; Wiens B; Calandra G
    N Engl J Med; 1992 Aug; 327(7):453-7. PubMed ID: 1320740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of the formalin-inactivated hepatitis A vaccine, VAQTA from the live attenuated virus strain CR326F.
    Armstrong ME; Giesa PA; Davide JP; Redner F; Waterbury JA; Rhoad AE; Keys RD; Provost PJ; Lewis JA
    J Hepatol; 1993; 18 Suppl 2():S20-6. PubMed ID: 8182268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The success of hepatitis A vaccine.
    Sjogren MH
    Gastroenterology; 1993 Apr; 104(4):1214-6. PubMed ID: 8385043
    [No Abstract]   [Full Text] [Related]  

  • 7. [Inactivated vaccine against hepatitis A: review of the literature and considerations on its use].
    Santos MV; Lopes MH
    Rev Soc Bras Med Trop; 1997; 30(2):145-57. PubMed ID: 9148338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Worldwide experience with the CR326F-derived inactivated hepatitis A virus vaccine in pediatric and adult populations: an overview.
    Nalin DR; Kuter BJ; Brown L; Patterson C; Calandra GB; Werzberger A; Shouval D; Ellerbeck E; Block SL; Bishop R
    J Hepatol; 1993; 18 Suppl 2():S51-5. PubMed ID: 8182275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Indications and prescription of hepatitis A vaccine in Spain. Report of the Spain Association for the Study of the Liver].
    Bruguera M; Buti M; Diago M; García Bengoechea M; Jara P; Pedreira JA; Ruiz Extremera A
    Gastroenterol Hepatol; 1997 Nov; 20(9):467-73. PubMed ID: 9445743
    [No Abstract]   [Full Text] [Related]  

  • 10. Control of hepatitis A by inactivated vaccines: unanswered questions and unresolved issues.
    Purcell RH
    J Hepatol; 1993; 18 Suppl 2():S61-4. PubMed ID: 8182277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Who in The Netherlands is eligible for immunization with inactivated hepatitis A vaccine?].
    Leentvaar-Kuijpers A
    Ned Tijdschr Geneeskd; 1994 May; 138(19):941-2. PubMed ID: 8196784
    [No Abstract]   [Full Text] [Related]  

  • 12. Protection of travelers against Hepatitis A viral infection in developing countries.
    Arya SC
    J Travel Med; 1998 Dec; 5(4):228-9. PubMed ID: 9935325
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparison of immunogenicity of two hepatitis A vaccines--VAQTA and HAVRIX--in young adults.
    Ashur Y; Adler R; Rowe M; Shouval D
    Vaccine; 1999 May; 17(18):2290-6. PubMed ID: 10403597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protection against hepatitis A by an inactivated vaccine.
    Innis BL; Snitbhan R; Kunasol P; Laorakpongse T; Poopatanakool W; Kozik CA; Suntayakorn S; Suknuntapong T; Safary A; Tang DB
    JAMA; 1994 May; 271(17):1328-34. PubMed ID: 8158817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Vaccination against hepatitis A].
    Germanaud J; Causse X
    Servir; 1994; 42(3):161-4. PubMed ID: 8059246
    [No Abstract]   [Full Text] [Related]  

  • 16. How an outbreak of hepatitis A in Melbourne led to the development of a vaccine.
    Gust ID
    Vaccine; 1992; 10 Suppl 1():S9. PubMed ID: 1335669
    [No Abstract]   [Full Text] [Related]  

  • 17. Hepatitis A vaccine.
    Longson PJ
    BMJ; 1992 Oct; 305(6858):888. PubMed ID: 1330143
    [No Abstract]   [Full Text] [Related]  

  • 18. Prevention of viral hepatitis A: past, present and future.
    Deinhardt F
    Vaccine; 1992; 10 Suppl 1():S10-4. PubMed ID: 1335635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis A outbreak in a socially-contained religious community in rural southern Ontario.
    Hockin J; Isaacs S; Kittle D; Brimmer G; Bailey N; Tamblyn S
    Can Commun Dis Rep; 1997 Nov; 23(21):161-6. PubMed ID: 9397602
    [No Abstract]   [Full Text] [Related]  

  • 20. Prevention of hepatitis A through active or passive immunization: Recommendations of the Advisory Committee on Immunization Practices (ACIP).
    MMWR Recomm Rep; 1996 Dec; 45(RR-15):1-30. PubMed ID: 9005304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.